Biochemical Analysis of a p53 Isoform that Accelerates Mammalian Aging

加速哺乳动物衰老的 p53 异构体的生化分析

基本信息

  • 批准号:
    8016662
  • 负责人:
  • 金额:
    $ 5.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-02-01 至 2012-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The p53 tumor suppressor plays critical roles in both cancer-prevention and aging. Activation of p53 response is important for its tumor suppressor function; conversely, shutting off active p53 is critical to prevent premature aging. This dual role of p53 in cancer and aging is perhaps best demonstrated by the activity of a naturally-occurring isoform of p53 called Np53 (a.k.a. 40p53). When over-expressed in mice (together with wild-type p53), Np53 causes hyper-activation of p53 target genes; although this results in enhanced tumor suppression, the mice also age rapidly and die prematurely. The hyper-active p53 response caused by Np53 has been linked to transcription activation. Because p53 binds DNA and activates transcription as a tetramer, the formation of p53/ Np53 hetero-tetramers is believed to cause the enhanced gene expression and accelerated aging. However, the molecular mechanism by which this occurs is largely unexplored. In this proposal, we outline a series of experiments that will begin to define the molecular mechanisms by which Np53 functions within the context of the p53 tetramer. Central to this work is a detailed biochemical analysis of mixed p53/ Np53 tetramers in the context of a native p53 target gene using a reconstituted human transcription system. In addition, we will identify which p53 target genes are differentially impacted by p53/ Np53 in human cells by performing mRNA analysis of 28 known p53 target genes. We will focus specifically on aging-related p53 targets in this screen to determine which might be altered most significantly by the Np53 isoform. Taken together, these biochemical and cell-based studies will begin to define the molecular mechanisms that enable the Np53 isoform to accelerate mammalian aging. PUBLIC HEALTH RELEVANCE: Our research analyzes the basic mechanisms of gene expression-what turns a gene "on" or "off" in a cell. Understanding this process is vital because proper regulation of gene expression is essential for virtually every major physiological process; furthermore, breakdown in this regulation is a hallmark of human disease, most notably cancer. In this proposal we will examine the function of an improperly activated protein called p53. Understanding how p53 functions, particularly in its abnormal, "hyper-active" state, lies at the heart of the cancer and aging problem because the form of p53 we are studying shows enhanced ability to prevent cancer yet concomitantly shortens lifespan. The precise mechanisms by which this occurs are not at all understood and will be explored in this study. We anticipate that the information accumulated by our efforts will identify new strategies for controlling the transcriptional activity of p53.
描述(由申请人提供):p53肿瘤抑制因子在癌症预防和衰老中起着关键作用。p53反应的激活对其肿瘤抑制功能很重要;相反,关闭活性p53对防止过早衰老至关重要。p53在癌症和衰老中的这种双重作用可能最好地通过称为Np 53(a.k.a. 40页53)。当Np 53在小鼠中过度表达时(与野生型p53一起),Np 53会导致p53靶基因的过度激活;尽管这会导致增强的肿瘤抑制,但小鼠也会迅速衰老并过早死亡。由Np 53引起的过度活跃的p53反应与转录激活有关。由于p53结合DNA并作为四聚体激活转录,因此p53/Np 53异源四聚体的形成被认为导致基因表达增强和加速衰老。然而,这种情况发生的分子机制在很大程度上尚未探索。在这个建议中,我们概述了一系列的实验,将开始,以确定的分子机制,其中Np 53的功能范围内的p53四聚体。这项工作的核心是一个详细的生物化学分析的混合p53/Np 53四聚体的背景下,一个天然的p53靶基因使用重建的人类转录系统。此外,我们将通过对28个已知的p53靶基因进行mRNA分析,确定哪些p53靶基因在人类细胞中受到p53/Np 53的差异影响。我们将特别关注与衰老相关的p53靶点,以确定哪些可能被Np 53亚型改变得最显著。总之,这些生物化学和细胞为基础的研究将开始,以确定分子机制,使Np 53亚型,以加速哺乳动物衰老。 公共卫生相关性:我们的研究分析了基因表达的基本机制--是什么在细胞中打开或关闭基因。了解这个过程是至关重要的,因为基因表达的适当调节几乎对每一个主要的生理过程都是必不可少的;此外,这种调节的破坏是人类疾病的标志,最明显的是癌症。在这个建议中,我们将研究一种被称为p53的不适当激活的蛋白质的功能。了解p53如何发挥作用,特别是在其异常的“过度活跃”状态下,是癌症和衰老问题的核心,因为我们正在研究的p53形式显示出预防癌症的能力增强,但同时缩短了寿命。发生这种情况的确切机制根本不清楚,将在本研究中进行探索。我们预计,通过我们的努力积累的信息将确定新的策略来控制p53的转录活性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dylan J Taatjes其他文献

Dylan J Taatjes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dylan J Taatjes', 18)}}的其他基金

Mechanisms of RNA polymerase II transcription regulation
RNA聚合酶II转录调控机制
  • 批准号:
    10321903
  • 财政年份:
    2021
  • 资助金额:
    $ 5.97万
  • 项目类别:
Supplemental request for MAX-TL Ultracentrifuge and rotor
MAX-TL 超速离心机和转子的补充请求
  • 批准号:
    10386257
  • 财政年份:
    2021
  • 资助金额:
    $ 5.97万
  • 项目类别:
Mechanisms of RNA polymerase II transcription regulation
RNA聚合酶II转录调控机制
  • 批准号:
    10536613
  • 财政年份:
    2021
  • 资助金额:
    $ 5.97万
  • 项目类别:
Mediator kinases as interferon antagonists in Down Syndrome
介导激酶作为唐氏综合症干扰素拮抗剂
  • 批准号:
    10461951
  • 财政年份:
    2020
  • 资助金额:
    $ 5.97万
  • 项目类别:
Mediator kinases as interferon antagonists in Down Syndrome
介导激酶作为唐氏综合症干扰素拮抗剂
  • 批准号:
    10677733
  • 财政年份:
    2020
  • 资助金额:
    $ 5.97万
  • 项目类别:
Mediator kinases as interferon antagonists in Down Syndrome
介导激酶作为唐氏综合症干扰素拮抗剂
  • 批准号:
    10114912
  • 财政年份:
    2020
  • 资助金额:
    $ 5.97万
  • 项目类别:
Mediator kinases as interferon antagonists in Down Syndrome
介导激酶作为唐氏综合症干扰素拮抗剂
  • 批准号:
    10268243
  • 财政年份:
    2020
  • 资助金额:
    $ 5.97万
  • 项目类别:
Mediator Kinases and Transcription Regulation
介导激酶和转录调控
  • 批准号:
    9113194
  • 财政年份:
    2016
  • 资助金额:
    $ 5.97万
  • 项目类别:
Mediator Kinases and Transcription Regulation
介导激酶和转录调控
  • 批准号:
    9306137
  • 财政年份:
    2016
  • 资助金额:
    $ 5.97万
  • 项目类别:
Biochemical Analysis of a p53 Isoform that Accelerates Mammalian Aging
加速哺乳动物衰老的 p53 异构体的生化分析
  • 批准号:
    7773565
  • 财政年份:
    2010
  • 资助金额:
    $ 5.97万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 5.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 5.97万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 5.97万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 5.97万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 5.97万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 5.97万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 5.97万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 5.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 5.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 5.97万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了